Stay updated on CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry (v3.5.4) was added to the record history, superseding the previous version (v3.5.3) and updating the page's version history.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page’s UI revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a system/interface update rather than a change to the study record contents.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded Revision: v3.5.0 to the history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check79 days agoChange DetectedRecord history shows the addition of revision v3.4.3 and the removal of revision v3.4.2.SummaryDifference0.1%

- Check108 days agoChange DetectedThe page footer now displays Revision: v3.4.2 instead of v3.4.1.SummaryDifference0.1%

Stay in the know with updates to CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.